Sustained Improvement in Patient-Reported Outcomes with Continued Apremilast Treatment over 104 Weeks in Patients with Moderate to Severe Psoriasis

Main Article Content

M Shane Chapman
Joshua Cirulli
Sandy McBride

Keywords

apremilast, psoriasis

Abstract

Abstract not available.

 

Disclosures: Study supported by Celgene.

 

Copyright SKIN 2018